Il rapporto
Notizie verificate su finanziamenti, sedi centrali e leadership delle aziende più innovative al mondo
53 report e oltre
Slingshot Biosciences Appoints Dr. Nimisha Srivastava CEO
Slingshot Biosciences promoted Chief Operating Officer Dr. Nimisha Srivastava to CEO to lead commercial growth and product development.
Twist Bioscience Raises $200M in Convertible Note
Twist Bioscience, a Biotech company based in 681 Gateway Boulevard, South San Francisco, CA 94080, has raised $200M in Convertible Note at a $4B valuation led by Temasek Holdings, Fidelity, Paladin Capital Group, Casdin Capital.
Twist Bioscience raises $200M Convertible Note at $4B valuation
Twist Bioscience raises $200M in Convertible Note at $4B valuation. Synthetic DNA manufacturing...
Twist Bioscience secures $120M Series D for biotech innovation
Twist Bioscience raises $120M in Series D funding to advance its synthetic biology company manufacturing dna sequences and accelerate market growth.
Treeline Biosciences Raises $200M in Series A
Treeline Biosciences, a HealthTech company based in San Diego, CA, has raised $200M in Series A from multiple investors.
Serán Bioscience Raises $200M in Venture
Serán Bioscience, a Biotech company based in Bend, OR, has raised $200M in Venture at a $900M valuation led by Foresite Capital, OrbiMed.
Retro Biosciences Raises $1B in Seed
Retro Biosciences, a HealthTech company based in San Francisco, CA, has raised $1B in Seed led by Sandro Salsano.
Syndeio Biosciences Raises $90M in Series
Syndeio Biosciences, a Biotech company based in Indianapolis, IN, has raised $90M in Series at a $450M valuation led by Eli Lilly and Company, ARCH Venture Partners.
Colossal Biosciences Raises $120M in Series
Colossal Biosciences, a Biotech company based in Austin, TX, has raised $120M in Series at a $800M valuation led by CIA In-Q-Tel, Breyer Capital.
Visualizzazione di 9 report • Pagina 1 • Categoria: all
Rimani avanti rispetto al mercato
Ricevi insight settimanali nella tua casella di posta. Niente spam, solo intelligenza.